(A) Timing of doxycycline induction and sample harvest in control, KRT14-rtTA;tetO-Cre;Bmpr1afl/fl (K;T;B) and KRT14-rtTA;tetO-Cre;Tgfbr2fl/fl (K;T;T) mice. (B, C) Macroscopic views of control compared to KRT14-rtTA;tetO-Cre;Bmpr1afl/fl lower first molars (B) and control compared to KRT14-rtTA;tetO-Cre;Tgfbr2fl/fl lower first molars (C) at PN48.5. (D-G) H&E staining of control compared to KRT14-rtTA;tetO-Cre;Bmpr1afl/fl lower first molars (D, F) and control compared to KRT14-rtTA;tetO-Cre;Tgfbr2fl/fl lower first molars (E, G) at PN7.5. Red arrows indicate the HERS. Red broken line in (F) indicates the cervical loop. (H-K)
In situ hybridization of Amelogenin in control compared to KRT14-rtTA;tetO-Cre;Bmpr1afl/fl lower first molars (H, I) and control compared to KRT14-rtTA;tetO-Cre;Tgfbr2fl/fl lower first molars (J, K) at PN7.5. Black arrows indicate Amelogenin expression, whereas arrowhead indicates lack of expression. (L-O) Immunofluorescence of Sox2 (green) in control compared to KRT14-rtTA;tetO-Cre;Bmpr1afl/fl lower first molars (L, M) and control compared to KRT14-rtTA;tetO-Cre;Tgfbr2fl/fl lower first molars (N, O) at PN7.5. White arrow indicates expression, whereas white arrowheads indicate absence of expression. Scale bars: 50μm.